Board of Directors
MBA (HEC) Founder & CEO SpePharm Holding BV 2006-2012. CEO OTL Pharma SA 2001-2004, COO ProStrakan UK 2004-2005.
Founder & Supervisory Board President Compte-Nickel. Adviser to CEO BNP Paribas. Prev President & CEO Boursorama.
IEP / Sc.Po, Master in Public Law. Co-Founder Eponyme Partners. CEO & Co-founder PPRS. Compagnie Financière E. de Rothschild, BNP Paribas.
HEC. Board Member at Jellagen. Prev CEO Mayoly-Spindler, EVP Europe Smith&Nephew, EVP Corporate Development IPSEN.
Executive Team
HEC. Board Member at Jellagen. Prev CEO Mayoly-Spindler, EVP Europe Smith&Nephew, EVP Corporate Development IPSEN.
Pharm D, MSc Tox, MSc Anatomopathology, American Board of Toxicology. Sr VP Neurosciences R&D, Ipsen
PhD in genetics and cell biochemistry. Development expertise in oncology, neurology and endocrinology. Ipsen, PNP Pharmac
MD. Statistics DIU (Cesam). Ipsen Medical Dvt Dir, Clin Dvt Dir.
Founder, PDR for Pharma. Ipsen VP North American Reg Aff,Biomeasure, Pharma Dvt Resources, Sepracor, Parexel, Interferon Sciences
Engineer, Research Master in Business Mgt. Covage, Bryan Garnier
Scientific Advisory Board
MD PhD. Hosp. Practitioner, Dpt of neonatal, pediatric & adult pain and palliative medicine, Hop Necker Enfants Malades, Paris, France.
Prof of Medicine. Stanford U Dpt of Oncology, Faisal Intl Prize, Damashek Prize, American Cancer Society’s Medal of Honor,
Prof Therapeutics, Paris VII U. Previously : Head Intl Med & Inf Dis H. Lariboisière, expert EMA, VP ANSM Drug Auth Ctee & Transparency Ctee
Pharm D, Hosp. Pharmacist, APHP Paris. Prof, Faculty of Pharmacy, Paris. Erasmus Prof, Portugal. Prev Member of French Medicines Agency ANSM
Pharmacist, Medical Doctor and Pharmacologist. Professor of Medical Pharmacology, former President of the Université d’Auvergne, France.
Assoc Prof of Medicine. Head of Medical Onclogy Hospital Unit, Gustave Roussy, France.
MD. Prof Neurology, Harvard Med School. Dir Cntr for Autonomic and Periph Nerve Disorders at Beth Israel Deaconess Medical Ctr, Boston, Ma.